PPARD and malignant colon neoplasm: This illustrates two important points: (1) downregulation of PPARβ/δ expression does not appear to be a mechanism by which NSAIDs inhibit colon cancer, and (2) IHC analyses of PPARβ/δ expression can be misleading, most likely influenced by non-specific binding of anti-PPARβ/δ antibodies.